Article info

Download PDFPDF

Original research
Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity

Authors

  • Adi Reches The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Yael Ophir The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Natan Stein The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Inbal Kol The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Batya Isaacson The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Yoav Charpak Amikam The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Afek Elnekave The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Pinchas Tsukerman The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Paola Kucan Brlic Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia PubMed articlesGoogle scholar articles
  • Tihana Lenac Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia PubMed articlesGoogle scholar articles
  • Barbara Seliger Institute of Medical Immunology, Martin-Luther-Universitat Halle-Wittenberg, Halle, Sachsen-Anhalt, Germany PubMed articlesGoogle scholar articles
  • Stipan Jonjic Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia PubMed articlesGoogle scholar articles
  • Ofer Mandelboim The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Hebrew University Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Ofer Mandelboim; oferm{at}ekmd.huji.ac.il
View Full Text

Citation

Reches A, Ophir Y, Stein N, et al
Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity

Publication history

  • Accepted April 7, 2020
  • First published June 4, 2020.
Online issue publication 
June 04, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.